Benjamin D, Robay D, Hindupur SK, et al. Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells. Cell Rep. 2018;25(11):3047-58.e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Payen VL, Mina E, Van Hée VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48–66.

Article  CAS  PubMed  Google Scholar 

Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells. 2021. https://doi.org/10.3390/cells10051056.

Article  PubMed  PubMed Central  Google Scholar 

Du W, Zang B, Wo Y, Chen S. SLC16A3 (MCT4) expression in tumor immunity and metabolism: insights from pan-cancer analysis. Biochem Biophys Rep. 2025;42:102034.

CAS  PubMed  PubMed Central  Google Scholar 

Buyse C, Joudiou N, Warscotte A, et al. Evaluation of syrosingopine, an MCT inhibitor, as potential modulator of tumor metabolism and extracellular acidification. Metabolites. 2022. https://doi.org/10.3390/metabo12060557.

Article  PubMed  PubMed Central  Google Scholar 

Benjamin D, Colombi M, Hindupur SK, et al. Syrosingopine sensitizes cancer cells to killing by metformin. Sci Adv. 2016;2(12):e1601756.

Article  PubMed  PubMed Central  Google Scholar 

Benjamin D. An acid test for metformin. J Pathol. 2023;260(4):365–7.

Article  CAS  PubMed  Google Scholar 

Van der Vreken A, Oudaert I, Ates G, et al. Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis. J Pathol. 2023;260(2):112–23.

Article  PubMed  Google Scholar 

Wu S, Xu L, He C, et al. Lactate efflux inhibition by syrosingopine/LOD co-loaded nanozyme for synergetic self-replenishing catalytic cancer therapy and immune microenvironment remodeling. Adv Sci Weinh. 2023;10(26):e2300686.

Article  PubMed  PubMed Central  Google Scholar 

Yang C, Wang M, Chang M, et al. Heterostructural nanoadjuvant CuSe/CoSe(2) for potentiating ferroptosis and photoimmunotherapy through intratumoral blocked lactate efflux. J Am Chem Soc. 2023;145(13):7205–17.

Article  CAS  PubMed  Google Scholar 

Zhao J, Tian Z, Zhao S, et al. Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity. Adv Sci Weinh. 2023;10(4):e2204808.

Article  PubMed  Google Scholar 

Yang Z, Zhou Y, Liu X, et al. Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells. Biomaterials. 2025;314:122883.

Article  CAS  PubMed  Google Scholar 

Bräutigam K, Straub J, Bihi AK, et al. Dual inhibition of lactate transporters MCT1 and MCT4 in pancreatic neuroendocrine tumors targets metabolic heterogeneity and functional redundancy. bioRxiv. 2025:2025.01.31.635625.

Guo M, Gou Y, Dong X, et al. Syrosingopine, an anti-hypertensive drug and lactate transporter (MCT1/4) inhibitor, activates hepatic stellate cells and exacerbates liver fibrosis in a mouse model. Genes Dis. 2024;11(4):101169.

Article  CAS  PubMed  Google Scholar 

Lefèvre-Borg F, Mathias O, Cavero I. Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats. Hypertension. 1988;11(4):360–70.

Article  PubMed  Google Scholar 

Walsh TJ, Palfai T. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia. Pharmacol Biochem Behav. 1979;11(4):449–52.

Article  CAS  PubMed  Google Scholar 

Shibuya T, Sato K. Fluorescence histochemical studies of the effects of rauwolfia alkaloid derivatives on adrenergic vasomotor nerves. Int J Clin Pharmacol Ther. 1985;23(1):5–10.

CAS  Google Scholar 

Loeffler LJ, Schran HF. Antibody specificity studies for reserpine, its metabolites, and synthetic reserpine congeners: radioimmunoassay. J Pharm Sci. 1979;68(11):1433–5.

Article  CAS  PubMed  Google Scholar 

Brown OM, Palfai T, Wichlinski L. Effect of an amnesic dose of reserpine, syrosingopine or guanethidine on the levels of whole brain dopamine and norepinephrine in the mouse. Pharmacol Biochem Behav. 1981;15(6):911–4.

Article  CAS  PubMed  Google Scholar 

Bilski A, Robertson HH, Wale JL. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clin Exp Pharmacol Physiol. 1979;6(1):1–9.

Article  CAS  PubMed  Google Scholar 

Barrett AM, Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970;40(3):373–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blackman JG, Campion DS, Fastier FN. Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse. Br J Pharmacol Chemother. 1959;14(1):112–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walsh TJ, Palfai T. Memory storage impairment or retrieval failure: pharmacologically distinguishable processes. Pharmacol Biochem Behav. 1979;11(4):453–6.

Article  CAS  PubMed  Google Scholar 

Li Y, Song Y, Shi Z, et al. Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response. Cell Death Dis. 2024;15(6):431.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadahiro Y, Nishimura S, Hitora Y, Tsukamoto S. Syrosingopine enhances 20S proteasome activity and degradation of α-synuclein. J Nat Prod. 2024;87(3):554–9.

Article  CAS  PubMed  Google Scholar 

Saulle E, Spinello I, Quaranta MT, et al. Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol. 2020;10:621458.

Article  PubMed  Google Scholar 

Faghihkhorasani F, Moosavi M, Rasool Riyadh Abdulwahid AH, et al. Role of monocarboxylate transporters in cancer immunology and their therapeutic potential. Br J Pharmacol. 2025. https://doi.org/10.1111/bph.70110.

Article  PubMed  Google Scholar 

Behera MM, Purkait S, Ghosh A, Sable MN, Sahu RN, Chhabra G. The monocarboxylate transporters MCT1 and MCT4 are highly expressed in glioblastoma and crucially implicated in the pathobiology. Neuropathology. 2025;45(4):e70006.

Article  CAS  PubMed  Google Scholar 

Chen L, Lin Y, Zhu X, et al. MCT1-mediated lactate shuttle to mitochondria governs macrophage polarization and modulates glucose homeostasis by affecting β cells. Adv Sci. 2025. https://doi.org/10.1002/advs.202414760.

Article  Google Scholar 

Wang N, Jiang X, Zhang S, et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell. 2021;184(2):370-83.e13.

Article  CAS  PubMed  Google Scholar 

Zhao B, Aggarwal A, Im SY, Viswanathan K, Landa I, Nehs MA. Effect of lactate export inhibition on anaplastic thyroid cancer growth and metabolism. J Am Coll Surg. 2022;234(6):1044–50.

Article  PubMed  Google Scholar 

Tian LR, Lin MZ, Zhong HH, et al. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Biomater Sci. 2022;10(14):3892–900.

Article  CAS  PubMed  Google Scholar